Safety and efficacy of coronavirus disease 2019 (COVID-19) mRNA vaccines during lactation

LL Shook, AG Edlow - Obstetrics & Gynecology, 2023 - journals.lww.com
safety and side-effect profile of coronavirus disease 2019 (COVID-19) vaccines during
lactation to date, review what is known about mRNA vaccine components in breast milk …

Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial

PT Heath, EP Galiza, DN Baxter… - … Infectious Diseases, 2023 - academic.oup.com
… high efficacy against the Alpha variant [18] and 96.4% efficacy … Here, we provide study results
for safety and efficacy through … For this analysis, safety and efficacy data from this ongoing …

Safety and efficacy of coronavirus disease‐19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review

N Mehta, S Shah, K Paudel… - Health Science …, 2022 - Wiley Online Library
… % coronavirus disease (COVID-19) mortality rate that has been underrepresented in COVID-…
studies to determine the safety and efficacy of the COVID-19 vaccination in chronic kidney …

Safety and efficacy of bronchoscopy in critically ill patients with coronavirus disease 2019

SH Chang, J Jiang, ZN Kon, DM Williams, TC Geraci… - Chest, 2021 - journal.chestnet.org
… the safety and feasibility of performing bronchoscopy with intermittent apnea for patients with
severe COVID-… is unusually high compared with non-COVID-19 ARDS. This increased need …

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

…, M Puoti, Niguarda COVID-19 Working Group - Journal of Infection, 2020 - Elsevier
… might be the driver of severe diseases. We report the safety and efficacy (in terms of overall
survival and hospital discharge) of the anti-IL6 tocilizumab (TCZ) in subjects with COVID-19. …

Safety and efficacy of Paxlovid against Omicron variants of coronavirus disease 2019 in elderly patients

C Weng, R Xie, G Han, Y Yuan, S Li, C Wang… - Infectious Diseases and …, 2023 - Springer
… Elderly patients are the most affected and vulnerable to COVID-19 and effective … safety
and efficacy of Paxlovid in the treatment of elderly patients with coronavirus disease 2019 (COVID

Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis

D Huang, H Yu, T Wang, H Yang… - Journal of medical …, 2021 - Wiley Online Library
… to evaluate the efficacy and safety of umifenovir in coronavirus disease 2019 (COVID-19). We
… ) were applied to assess the effectiveness of umifenovir for COVID-19. A total of 12 studies …

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

FP Polack, SJ Thomas, N Kitchin… - New England journal …, 2020 - Mass Medical Soc
… , we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 trial
evaluating the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-…

A phase II safety and efficacy study on prognosis of moderate pneumonia in coronavirus disease 2019 patients with regular intravenous immunoglobulin therapy

RS Raman, V Bhagwan Barge… - … Infectious Diseases, 2021 - academic.oup.com
… no specific drug for the treatment of coronavirus disease 2019 (COVID-19). … diseases. The
present study is conducted to evaluate the safety and efficacy of IVIG in the treatment of COVID

Safety and efficacy of NVX-CoV2373 Covid-19 vaccine

PT Heath, EP Galiza, DN Baxter, M Boffito… - … England Journal of …, 2021 - Mass Medical Soc
… had emerged as safe and effective in preventing coronavirus disease 2019 (Covid-19), … ,
more severe disease, and varying degrees of immune avoidance to Covid-19 vaccines. In the …